Companies in #Dermatology

Shanghai Ark Biopharmaceutical (ArkBio) is a clinical-stage biotech developing antiviral therapeutics, including ziresovir, an RSV antiviral drug.

Celldex Therapeutics is a clinical-stage biotechnology company developing antibody-based therapies targeting inflammatory and allergic diseases. Recently scrapped its antibody for prurigo nodularis after a Phase 2 flop.

DifGen Pharmaceuticals is a specialty pharma company. See today's news for the latest developments.

Leo Pharma is a privately held Danish dermatology company developing treatments for skin diseases including psoriasis, eczema, and rare conditions like generalized pustular psoriasis (GPP).

Oak Hill Bio is a dermatology company. See today's news for the latest developments.

Phothera is a phototherapy medical device company. Recently announced that Aetna updated its coverage policy to include home phototherapy for vitiligo treatment, effective July 2026.

Biopharmaceutical company focused on developing novel therapies for autoimmune and inflammatory diseases. Its lead asset LISRAYA (brepocitinib) received FDA approval for dermatomyositis, with Orsini Specialty Pharmacy serving as the specialty pharmacy partner.

Clinical-stage immunoregulatory therapeutics company built on tissue regulatory T cell biology, combining high-resolution human tissue sequencing, computational biology and translational assay systems in its Deep Biology platform.

Washington, DC-based biopharmaceutical company developing and commercializing therapies for central nervous system disorders, dermatologic conditions, and rare diseases, with three FDA-approved products on market.

New Haven, CT-based dermatology biotech developing dissolvable microarray patches for pattern hair loss (androgenetic alopecia), with a clinical-stage lead candidate.